197 related articles for article (PubMed ID: 28813011)
21. A significant decrease of the transcriptional activity of p53 mutants deriving from human functional adrenal tumors.
Lin SR; Yang YC; Jung JH; Tsai JH
DNA Cell Biol; 1996 Oct; 15(10):793-803. PubMed ID: 8892752
[TBL] [Abstract][Full Text] [Related]
22. Effects of temperature on the p53-DNA binding interactions and their dynamical behavior: comparing the wild type to the R248Q mutant.
Barakat K; Issack BB; Stepanova M; Tuszynski J
PLoS One; 2011; 6(11):e27651. PubMed ID: 22110706
[TBL] [Abstract][Full Text] [Related]
23. New insights into p53 function from structural studies.
Arrowsmith CH; Morin P
Oncogene; 1996 Apr; 12(7):1379-85. PubMed ID: 8622853
[TBL] [Abstract][Full Text] [Related]
24. Regulation of mutant p53 temperature-sensitive DNA binding.
Friedlander P; Legros Y; Soussi T; Prives C
J Biol Chem; 1996 Oct; 271(41):25468-78. PubMed ID: 8810317
[TBL] [Abstract][Full Text] [Related]
25. Structural and sequential context of p53: A review of experimental and theoretical evidence.
Saha T; Kar RK; Sa G
Prog Biophys Mol Biol; 2015 Mar; 117(2-3):250-263. PubMed ID: 25550083
[TBL] [Abstract][Full Text] [Related]
26. Mutants of the tumour suppressor p53 L1 loop as second-site suppressors for restoring DNA binding to oncogenic p53 mutations: structural and biochemical insights.
Merabet A; Houlleberghs H; Maclagan K; Akanho E; Bui TT; Pagano B; Drake AF; Fraternali F; Nikolova PV
Biochem J; 2010 Mar; 427(2):225-36. PubMed ID: 20113312
[TBL] [Abstract][Full Text] [Related]
27. Genetic selection of intragenic suppressor mutations that reverse the effect of common p53 cancer mutations.
Brachmann RK; Yu K; Eby Y; Pavletich NP; Boeke JD
EMBO J; 1998 Apr; 17(7):1847-59. PubMed ID: 9524109
[TBL] [Abstract][Full Text] [Related]
28. Insight into a novel p53 single point mutation (G389E) by Molecular Dynamics Simulations.
Pirolli D; Carelli Alinovi C; Capoluongo E; Satta MA; Concolino P; Giardina B; De Rosa MC
Int J Mol Sci; 2010 Dec; 12(1):128-40. PubMed ID: 21339981
[TBL] [Abstract][Full Text] [Related]
29. Stabilization of mutant p53 via alkylation of cysteines and effects on DNA binding.
Kaar JL; Basse N; Joerger AC; Stephens E; Rutherford TJ; Fersht AR
Protein Sci; 2010 Dec; 19(12):2267-78. PubMed ID: 20878668
[TBL] [Abstract][Full Text] [Related]
30. The screening of the second-site suppressor mutations of the common p53 mutants.
Otsuka K; Kato S; Kakudo Y; Mashiko S; Shibata H; Ishioka C
Int J Cancer; 2007 Aug; 121(3):559-66. PubMed ID: 17417775
[TBL] [Abstract][Full Text] [Related]
31. Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes.
Scian MJ; Stagliano KE; Deb D; Ellis MA; Carchman EH; Das A; Valerie K; Deb SP; Deb S
Oncogene; 2004 May; 23(25):4430-43. PubMed ID: 15077194
[TBL] [Abstract][Full Text] [Related]
32. Wild type p53 function in p53
Sundar D; Yu Y; Katiyar SP; Putri JF; Dhanjal JK; Wang J; Sari AN; Kolettas E; Kaul SC; Wadhwa R
J Exp Clin Cancer Res; 2019 Feb; 38(1):103. PubMed ID: 30808373
[TBL] [Abstract][Full Text] [Related]
33. Effects of oncogenic mutations and DNA response elements on the binding of p53 to p53-binding protein 2 (53BP2).
Tidow H; Veprintsev DB; Freund SM; Fersht AR
J Biol Chem; 2006 Oct; 281(43):32526-33. PubMed ID: 16887812
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the combined effect of p53 codon 72 polymorphism and hotspot mutations in response to anticancer drugs.
Vikhanskaya F; Siddique MM; Kei Lee M; Broggini M; Sabapathy K
Clin Cancer Res; 2005 Jun; 11(12):4348-56. PubMed ID: 15958617
[TBL] [Abstract][Full Text] [Related]
35. Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein.
Liu WL; Midgley C; Stephen C; Saville M; Lane DP
J Mol Biol; 2001 Nov; 313(4):711-31. PubMed ID: 11697899
[TBL] [Abstract][Full Text] [Related]
36. Restoring wild-type conformation and DNA-binding activity of mutant p53 is insufficient for restoration of transcriptional activity.
Brazda V; Muller P; Brozkova K; Vojtesek B
Biochem Biophys Res Commun; 2006 Dec; 351(2):499-506. PubMed ID: 17070499
[TBL] [Abstract][Full Text] [Related]
37. Ellipticine induces apoptosis in T-cell lymphoma via oxidative DNA damage.
Savorani C; Manfé V; Biskup E; Gniadecki R
Leuk Lymphoma; 2015 Mar; 56(3):739-47. PubMed ID: 24898668
[TBL] [Abstract][Full Text] [Related]
38. Structure and Function of p53-DNA Complexes with Inactivation and Rescue Mutations: A Molecular Dynamics Simulation Study.
Kamaraj B; Bogaerts A
PLoS One; 2015; 10(8):e0134638. PubMed ID: 26244575
[TBL] [Abstract][Full Text] [Related]
39. Intrinsically disordered domain of tumor suppressor p53 facilitates target search by ultrafast transfer between different DNA strands.
Itoh Y; Murata A; Takahashi S; Kamagata K
Nucleic Acids Res; 2018 Aug; 46(14):7261-7269. PubMed ID: 29986056
[TBL] [Abstract][Full Text] [Related]
40. The substitutions G245C and G245D in the Zn(2+)-binding pocket of the p53 protein result in differences of conformational flexibility of the DNA-binding domain.
Pintus SS; Ivanisenko NV; Demenkov PS; Ivanisenko TV; Ramachandran S; Kolchanov NA; Ivanisenko VA
J Biomol Struct Dyn; 2013; 31(1):78-86. PubMed ID: 22803791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
